Lupin secures tentative USFDA nod for multiple sclerosis drug Siponimod Ruchika Sharma5 Dec 2025 11:10 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...
Lupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US Ruchika Sharma4 Dec 2025 2:14 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics, a ...
Lupin secures USFDA nod for biosimilar Armlupeg Ruchika Sharma1 Dec 2025 10:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has approved Armlupeg...
Lupin gets seven USFDA observations for Goa facility Ruchika Sharma22 Nov 2025 11:43 AM ISTMumbai: Lupin has announced that the company has received seven observations from the U.S. Food and Drug Administration (USFDA) after an...
Lupin secures S&P Global ESG Score of 91 for 2025 Ruchika Sharma17 Nov 2025 12:34 PM ISTMumbai: Global pharma firm Lupin Limited has announced that it has achieved an S&P Global ESG Score of 91 for 2025, well above the...
Lupin Nagpur facility completes USFDA inspection Ruchika Sharma15 Nov 2025 5:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a product...
Lupin unveils Risperidone Long Acting Injectable in US Ruchika Sharma14 Nov 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial,...
Lupin gets EIR from USFDA for Aurangabad Facility Ruchika Sharma13 Nov 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin Bioresearch Center gets zero USFDA observation after successful inspection, assessment Ruchika Sharma8 Nov 2025 3:08 PM ISTMumbai: Lupin Limited, a Global pharma major, has announced that the United States Food and Drug Administration (U.S. FDA) has...
Lupin gets USFDA EIR for Pithampur Unit 3 facility Ruchika Sharma6 Nov 2025 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin inaugrates new corporate offices in New Jersey Ruchika Sharma29 Oct 2025 11:30 AM ISTBridgewater: Global pharmaceutical leader, Lupin Limited, has announced the inauguration of its new corporate offices at 100 Somerset...
Lupin unveils authorized generic version of Ravicti in US Ruchika Sharma24 Oct 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of an authorized generic version of Ravicti (Glycerol Phenylbutyrate) Oral Liquid,...
